pitavastatin usually calcium salt member blood cholesterol lowering medication class like statins inhibitor hmgcoa reductase enzyme catalyses first step cholesterol synthesis patented approved medical use available japan south korea us received fda approval kowa pharmaceuticals subsidiary kowa company owner american patent pitavastatin like statins pitavastatin indicated hypercholesterolaemia elevated cholesterol prevention cardiovascular disease study lives trial found pitavastatin increased hdl cholesterol especially patients hdl lower mgdl rise addition greatly reducing ldl cholesterol hdl improved patients switched statins rose time circle observational study pitavastatin increased hdl neutral possibly beneficial effects glucose control consequence pitavastatin likely appropriate patients metabolic syndrome plus high ldl low hdl diabetes mellituscitation needed common statinrelated side effects headaches stomach upset abnormal liver function tests muscle cramps similar pitavastatin lipophillic reports indicate statin may lead fewer muscle side effects one study found coenzyme reduced much certain statins though unlikely given inherent chemistry hmgcoa reductase pathway statin drugs opposed statins evidence pitavastatin improves insulin resistance humans insulin resistance assessed homeostatic model assessment homair hyperuricemia increased levels serum uric acid reported statins metabolised part one hepatic cytochrome enzymes leading increased potential drug interactions problems certain foods grapefruit juice primary metabolism pathway pitavastatin glucuronidation minimally metabolized enzymes common source interactions statins result less likely interact drugs metabolized via might important elderly patients need take multiple pitavastatin previously known itavastatin itabavastin nisvastatin discovered japan nissan chemical industries developed kowa pharmaceuticals pitavastatin approved use united states fda trade name livalo pitavastatin also approved medicines healthcare products regulatory agency mhra uk august zypitamag pitavastatin magnesium pharmaceutical alternative livalo approved use united states fda drug marketed united states trade names livalo zypitamag european union russia trade name livazo httpsenwikipediaorgwikipitavastatin